Vanguard Group Inc Pro Phase Labs, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRPH
# of Institutions
27Shares Held
1.71MCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny215KShares$137,6700.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL179KShares$114,5880.0% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$102,8700.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL82.9KShares$53,0760.11% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA64.9KShares$41,5390.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $10.3M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...